Literature DB >> 10624885

Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats.

N K Jain1, S K Kulkarni.   

Abstract

Oral administration of the feverfew (Tanacetum parthenium) extract led to significant antinociceptive and anti-inflammatory effects against acetic acid-induced writhing in mice and carrageenan-induced paw edema in rats, respectively. These responses were dose-dependent (10, 20, 40 mg/kg, p.o.). Parthenolide (1, 2 mg/kg i.p.), the active constituent of the extract also produced antinociceptive and anti-inflammatory effects. Naloxone (1 mg/kg i.p.), an opiate antagonist, failed to reverse feverfew extract and parthenolide-induced antinociception. Feverfew extract in higher doses (40, 60 mg/kg p.o.) neither altered the locomotor activity nor potentiated the pentobarbitone-induced sleep time in mice. It also did not change the rectal temperature in rats. Feverfew extract exerted antinociceptive and anti-inflammatory effects without altering the normal behaviour of the animals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10624885     DOI: 10.1016/s0378-8741(99)00115-4

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  21 in total

1.  Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium.

Authors:  Tatiana Shioji Tiuman; Tânia Ueda-Nakamura; Diógenes Aparício Garcia Cortez; Benedito Prado Dias Filho; José Andrés Morgado-Díaz; Wanderley de Souza; Celso Vataru Nakamura
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.

Authors:  Aicha Saadane; Sophia Masters; Joseph DiDonato; Jingfeng Li; Melvin Berger
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

3.  Parthenolide attenuates 7,12-dimethylbenz[a]anthracene induced hamster buccal pouch carcinogenesis.

Authors:  Nagarethinam Baskaran; Govindan Sadasivam Selvam; Subramani Yuvaraj; Albert Abhishek
Journal:  Mol Cell Biochem       Date:  2017-08-12       Impact factor: 3.396

4.  Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury.

Authors:  Yuri Ozawa; Hiroyuki Kobori
Journal:  Am J Physiol Renal Physiol       Date:  2007-04-04

Review 5.  Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.

Authors:  Till Sprenger; M Viana; C Tassorelli
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

6.  Enhancement of 1 alpha,25-dihydroxyvitamin D(3)-induced differentiation of human leukaemia HL-60 cells into monocytes by parthenolide via inhibition of NF-kappa B activity.

Authors:  S N Kang; S H Kim; S W Chung; M H Lee; H J Kim; T S Kim
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

7.  Parthenolide inhibits proliferation of fibroblast-like synoviocytes in vitro.

Authors:  Jolanta Parada-Turska; Agata Mitura; Wojciech Brzana; Mirosław Jabłoński; Maria Majdan; Wojciech Rzeski
Journal:  Inflammation       Date:  2008-08       Impact factor: 4.092

8.  PEGylated Lipova E120 liposomes loaded with celecoxib: in-vitro characterization and enhanced in-vivo anti-inflammatory effects in rat models.

Authors:  Vivek Dave; Ashish Gupta; Priyanka Singh; Kajal Tak; Swapnil Sharma
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

9.  Feverfew (Tanacetum parthenium L.): A systematic review.

Authors:  Anil Pareek; Manish Suthar; Garvendra S Rathore; Vijay Bansal
Journal:  Pharmacogn Rev       Date:  2011-01

10.  Parthenolide attenuates LPS-induced activation of NF-κB in a time-dependent manner in rat myocardium.

Authors:  Hong Xie; Chen Wang; Xuemei Wu; Xia Liu; Shigang Qiao; Chunfeng Liu; Hong Liu
Journal:  J Biomed Res       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.